Screener
Viridian Therapeutics, Inc. VRDN Accretion (Amortization) of Discounts and Premiums, Investments
Accretion (Amortization) of Discounts and Premiums, Investments at other companies
Other financials
Where this comes from
Reported directly by Viridian Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments.
The source filing: Viridian Therapeutics, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:31 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001590750-26-000018
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Share-based compensation expense | 30,374 | 21,064 |
| Non-cash interest expense | 4,882 | 206 |
| Depreciation and amortization | 238 | 230 |
| Accretion and amortization of available-for-sale securities | (3,308) | (3,872) |
| Non-cash lease expense | (28) | (17) |
| Change in fair value of derivative liability | (6,340) | — |
| Loss on extinguishment of debt | 4,449 | — |
| Changes in operating assets and liabilities: |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Viridian Therapeutics, Inc.'s accretion (amortization) of discounts and premiums, investments?
- Viridian Therapeutics, Inc. (VRDN) reported accretion (amortization) of discounts and premiums, investments of $1.45M in Q2 2026.
- How has Viridian Therapeutics, Inc.'s accretion (amortization) of discounts and premiums, investments changed year-over-year?
- Viridian Therapeutics, Inc.'s accretion (amortization) of discounts and premiums, investments decreased by 6.5% year-over-year, from $1.55M to $1.45M.
- What is the long-term trend for Viridian Therapeutics, Inc.'s accretion (amortization) of discounts and premiums, investments?
- Over 4 years (2021 to 2025), Viridian Therapeutics, Inc.'s accretion (amortization) of discounts and premiums, investments has grown at a 62.7% compound annual growth rate (CAGR), from -$965K to $6.76M.
- What does accretion (amortization) of discounts and premiums, investments mean?
- This represents the non-cash adjustment to interest income or expense resulting from the amortization of premiums or accretion of discounts on debt securities held as investments. It reflects the gradual adjustment of the carrying value of investment securities toward their face value over time. This metric is essential for reconciling net income to cash flow from operations by removing non-cash accounting impacts.
Ask your AI about Viridian Therapeutics, Inc.'s accretion (amortization) of discounts and premiums, investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude